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Abstract—To improve the recovery of damaged cartilage
tissue, pluripotent stem cell-based therapies are being inten-
sively explored. A number of techniques exist that enable
monitoring of stem cell differentiation, including immunoﬂu-
orescence staining. This simple and fast method enables
changes to be observed during the differentiation process.
Here, two protocols for the differentiation of human
embryonic stem cells into chondrocytes were used (mono-
layer cell culture and embryoid body formation). Cells were
labeled for markers expressed during the differentiation
process at different time points (pluripotent: NANOG,
SOX2, OCT3/4, E-cadherin; prochondrogenic: SOX6,
SOX9, Collagen type II; extracellular matrix components:
chondroitin sulfate, heparan sulfate; beta-catenin, CXCR4,
and Brachyury). Comparison of the signal intensity of
differentiated cells to control cell populations (articular
cartilage chondrocytes and human embryonic stem cells)
showed decreased signal intensities of pluripotent markers,
E-cadherin and beta-catenin. Increased signal intensities of
prochondrogenic markers and extracellular matrix compo-
nents were observed. The changes during chondrogenic
differentiation monitored by evaluation of pluripotent and
chondrogenic markers signal intensity were described. The
changes were similar to several studies over chondrogenesis.
These results were conﬁrmed by semi-quantitative analysis of
IF signals. In this research we indicate a bioimaging as a
useful tool to monitor and semi-quantify the IF pictures
during the differentiation of hES into chondrocyte-like.
Keywords—Immunoﬂuorescence, Chondrogenesis, Regener-
ative medicine, Osteoarthritis, Cartilage injuries.
INTRODUCTION
Articular cartilage is an avascular tissue composed
of extracellular matrix (ECM) and cartilage cells
(chondrocytes). The main components of ECM are
collagens type II, IX, and X, and proteoglycans such as
heparan sulfate, keratan sulfate, chondroitin sulfate,
and hyaluronic acid. Cartilage performs many impor-
tant biomechanical functions within the joint, such as
absorption of mechanical stress and reduction of fric-
tion of the articular surface, enabling painless motion.5
As a result of mechanical injuries or catabolic pro-
cesses (degradation of ECM components by metallo-
proteinases), chondrocytes become hyper-activated,
which triggers hypertrophy and the mineralisation
process. The limited regeneration capacity of damaged
tissue often leads to osteoarthritis. One procedure for
cartilage lesion repair is ﬁlling in of damage with
autologous chondrocytes propagated in vitro (autolo-
gous chondrocyte implantation).23 However, down-
regulation of genes responsible for the production
of speciﬁc ECM components, for example type II
collagen, alongside limited proliferation of primary
chondrocytes and their hypertrophic phenotype
development during cell culture, may result in loss of
tissue functionality after transplantation.11,56,57 One
predominant aim of studies in the area of cartilage
repair is to obtain fully functional tissue with the
properties of native cartilage.
Pluripotent stem cells, including human embryonic
stem cells (hESCs), induced-pluripotent stem cells
(iPSCs), and multipotent mesenchymal stem cells
(MSCs), are undergoing intensive investigation as
potential candidates for the treatment of numerous
degenerative diseases.17,55 Because chondrocytes develop
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from the mesoderm, MSCs are likely to be a suitable
cell source for cartilage regeneration. However,
obtaining MSCs requires an invasive bone marrow
biopsy. Another disadvantage of applying MSCs is
their low contribution to the population of bone mar-
row cells (below 0.001%).42 However, many studies
involved in characterization of cells population have
indicated an alternative source ofMSCs. They could be
found in adipose tissue, umbilical cord blood, syn-
ovium, dental pulp, placenta, etc.13,33 Owing to ethical
concerns for the application of hESCs, iPSCs are a
good candidate for stem cell-based therapies. To the
date, intensively researched reprogramming protocols
have led to readily obtaining iPS cells, which are con-
sidered safe in clinical practice applications. They give
a tremendous possibilities due to ability to differentiate
into most cells of organism and unlimited self-renewal
capacity. Studies over differentiation of hESCs and
iPSC allow to expand the knowledge of developmental
biology by tracking of variable molecular pathways,
which are activated during differentiation into various
progenitors. Additionally, they seems to be suitable
source of cells for drugs toxicity assays and disease
models.10,25,50,52
One major problem in the direct diﬀerentiation of
pluripotent cells into progenitor cells is that these
protocols result in obtaining a heterogeneous popula-
tion of diﬀerentiated cells. A second problem is in
achieving eﬃcient cell diﬀerentiation on a large scale.
Minor modiﬁcations of the protocols are now required
to obtain large homogenous cell populations without
increasing costs of potential therapy.8,43,51,55
At present, chondrocytes are obtained from the
diﬀerentiation of multipotent and pluripotent cells by
various protocols.2,12,39,54,61,62 These methods involve
supplementation of the culture medium with speciﬁc
growth factors, mainly bone morphogenetic proteins
(BMPs) and transforming growth factor-beta (TGF-b)
family members.35,54,61 These two protein families are
responsible for chondrocyte maturation from mes-
enchymal cells during bone and cartilage development
in the fetus. The results of numerous studies suggest
that TGF-b3 has the strongest prochondrogenic
properties compared with other growth factors.4,20,34,37
To the date, several improved protocols of in vitro
chondrogenesis have been published. These protocols
involve the induction of cartilage ECM components
produced by speciﬁc physical and chemical factors i.e.
hypoxic conditions of cell culture,24 three-dimensional
systems,30,60 exposure to low pulsating ultrasound6,41
and mechanical forces caused by centrifugation or
hydrostatic pressure.31,46 Moreover, research on bio-
materials has demonstrated their usefulness in improv-
ing the differentiation process and in vitro propagation
of cells.16,27,48,53,58
Various methods have been used to evaluate chan-
ges occurring within cells during the diﬀerentiation
process. Molecular analysis of these changes involves
detailed, expensive, complicated and time-consuming
procedures linked to sophisticated bioinformatics
analyses. However, some published protocols con-
cerning the evaluation of protein expression are simple,
speciﬁc and relatively inexpensive, for example,
immunoﬂuorescence (IF) labeling, which is commonly
used and accessible in most laboratories.38 The IF
technique allows researchers to evaluate levels of pro-
tein expression and monitor the number of biological
processes.32,47 Flow cytometry enables quantitative
and qualitative analysis of signal intensity and evalu-
ation of percentage distribution of positively labeled
cells within a sample population. However, this tech-
nique requires a large number of cells, the cost of the
apparatus is relatively high and analysis must be per-
formed by highly qualiﬁed staff.
Dynamic development of information technology has
led to an increased availability of numerous applications
for microscopic image analysis of various cells in vitro.
Furthermore, the use of appropriate software, allows for
rapid and cost-effective evaluation of the material, whilst
reducing the volume of sample required.
The aim of this study was to test, the usefulness of
semi-quantitative analysis of the signal intensity emit-
ted following IF of labeled cells during the diﬀerenti-
ation of hESCs into chondrocytes.
MATERIALS AND METHODS
hESC Culture
Human embryonic stem cells (BGV01) were
obtained from ATCC (VA, USA) and were cultured
on mitomycin-C-treated mouse embryonic ﬁbroblasts
(MEFs, passage 3, Merck Millipore, Darmstadt, Ger-
many) in hESC medium consisting of high-glucose
DMEM/F12 (Merck Millipore) supplemented with
15% fetal bovine serum (FBS, Sigma-Aldrich, St.
Louis, MO, USA), 5% knock-out serum replacement
(KSR, Thermo Fisher Scientiﬁc Inc., Waltham, MA,
USA), 1% penicillin–streptomycin (Sigma-Aldrich),
1 mM non-essential amino acid (NEAA, Merck Mil-
lipore), 0.2 mM 2-mercaptoethanol and 10 ng/mL
basic ﬁbroblast growth factor (bFGF, Merck Milli-
pore). Cell cultures were maintained at 37 C in a
humidiﬁed atmosphere containing 5% CO2.
Chondrogenic Diﬀerentiation of Embryoid Bodies
Embryoid bodies (EBs) were formed from previ-
ously trypsinized hESCs, which were seeded onto
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96-well plates (BRAND inertGradeTM, Wertheim,
Germany) at 1000 cells/well. At day 7, the 2 of EBs
were transferred into MatrigelTM-coated 48-well plates
(MatrigelTM, Corning, NY, USA) and after 24 h the
medium was switched to chondrogenic medium (ChM)
(day 0). ChM was composed of DMEM/F12 (Merck
Millipore), 10% FBS, 1 mM sodium pyruvate (Sigma-
Aldrich), 1027 M dexamethasone, 50 lM ascorbic
acid, 50 lM L-proline, 1% penicillin–streptomycin
(Sigma-Aldrich), 1% ITS+ premix (Corning, NY,
USA) and 10 ng/mL TGF-b3 (Immunotools, Frie-
soythe, Germany). Culture was carried out for 20 days
and the medium was changed every second day.
Chondrogenic Diﬀerentiation of Monolayer Cells
The protocol for monolayer diﬀerentiation of hESCs
into chondrocytes was established by Yang et al.,61
based on a simpliﬁed protocol by Oldershaw et al.39
Brieﬂy, cells were differentiated for 2 weeks using var-
ious concentrations of growth factors: Wnt-3a (wing-
less-type MMTV integration site family, member 3A),
activin-A (both from Sigma-Aldrich), growth/differen-
tiation factor 5 (GDF-5, Immunotools), ﬁbroblast
growth factor 2 (FGF-2, Merck Millipore), BMP-4
(bone morphogenetic protein 4, Sigma-Aldrich) and
follistatin (Peprotech, Rocky Hill, NJ, USA). 100,000
cells/well were seeded onto a six-well plate coated with
MatrigelTM. After cell attachment, the hESC medium
was switched to ChMwith cytokines. The time schedule
and concentration of cytokines added at each day of
differentiation are presented in Table S1 (supplemen-
tary data). Cells were cultured in serum-free ChM
supplementedwith 0.1%KSR (ThermoFisher Scientiﬁc
Inc., Waltham, MA, USA).
Indirect IF Staining
The 2 EBs, previously seeded onto 48-well plates,
were ﬂuorescently labeled at diﬀerent time points of
diﬀerentiation (days 0, 7, 14, and 21). Brieﬂy, cells were
washed with phosphate-buﬀered saline (PBS) and then
ﬁxed with cooled methanol for 20 min at 220 C.
Next, the cells were blocked with PBS containing 1%
BSA (bovine serum albumin) and 0.5% Tween. Cell
were then incubated for 1 h at 37 C with primary
antibodies diluted in PBS containing 1% BSA at pre-
viously optimized dilutions (a list of antibodies and
their dilutions used for immunocytochemistry are en-
closed in supplementary data, Table S2). After wash-
ing, a secondary antibody conjugated with Alexa-488
was added and the incubation was carried out for 1 h
at 37 C. After washing, the nuclei were stained with
4¢,6-Diamidino-2-phenylindole dihydrochloride (DAPI)
at 1:10,000 dilution (Sigma-Aldrich). Images were taken
using a Leica Series ﬂuorescent microscope at the same
time of exposure and gain, which was optimized for
each antibody. A feeder-free hESC cell line and primary
human articular cartilage chondrocytes (ACC) were
used as controls.
The Evaluation of IF-Labeled Signal
The intensity of the signals was evaluated (Fig. 1)
using the bioinformatics programme ImageJ version
1.49j (developed by Wayne Rasband, NIH, USA).
Images from the RGB format were converted into a
16-bit gray scale. Signal thresholds were set only in the
area of the positive-labeled cells. The marked areas
were described as a mean value of intensity of the
pixels (ranging from 0 (dark) to 255 (white)). Because
of non-speciﬁc signals such as non-speciﬁc binding or
unwashed secondary antibodies, cell aggregate signals
were excluded. After evaluation of the measurements,
quantiﬁcation of the positively stained cell population
was conducted to standardize the scores. This was
carried out by multiplication of the mean gray signals
by the ratio of positively stained cells to the number of
cells in the whole population. From the mean gray
signals obtained from cell colonies, total mean gray
values of the image were generated.
Statistical Analysis
The comparison of mean gray intensity signals
between two populations of diﬀerentiated cells and
control populations (ACC, hESCs, and cells exposed
to ChM) were evaluated by the unpaired tailed Student
t test (QuickCalcs, GraphPad online statistical calcu-
lator; GraphPad, La Jolla, CA, USA). There were
three levels of statistical signiﬁcance: p< 0.05 (signiﬁ-
cant), p< 0.01 (highly signiﬁcant), and p< 0.001 (ex-
tremely signiﬁcant). SEM were calculated from the
total mean gray intensity signals of gathered means
from three pictures from wells of three independent cell
cultures.
RESULTS
Diﬀerentiation of hESC into Chondrocytes
The procedure of diﬀerentiation according to
monolayer (2D) and EB (3D) diﬀerentiation protocols
caused changes in morphology of cultured cells. Dur-
ing the diﬀerentiation process, cell elongation and an
increased nucleus/cytoplasm ratio were observed
(supplementary data, Fig. S1A and B). During the ﬁrst
7 days of culture, growth factors, WNT-3a, BMP-4,
activin-A, follistatin, and FGF-2 were added to the
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prochondrogenic medium, resulting in the develop-
ment of mesoderm.39,61 Cells were then exposed to
GDF-5, which is a member of the TGF-beta protein
family, and after 14 days of culture chondrocyte-like
cells were observed.
EBs are heterogeneous cell populations consisting of
three germ layers. After attachment, the EB structures
became ﬂattened and cells of various shapes were
detected. After 21 days of culture, chondrocyte-like
cells were observed (Fig. S1, panel A). During diﬀer-
entiation at monolayer protocol, some cell detachment
was observed, likely owing to decreased cell viability of
some cells (Fig. S2). Previously, it was reported, that
cells, which failure to diﬀerentiate into chondrocytes,
die oﬀ.39,61 One of the reason was serum-free condi-
tions or less enriched medium in EBs protocol. For
FIGURE 1. Step-by-step instructions for analysis of immunofluorescence images.
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hESCs propagated in richer medium, the poorer con-
ditions could cause starvation stress. On the other
hand, the increased amount of dead cells in EBs based
protocol could be related to preparation of EBs by
dissociation of hESCs to single cells, what decrease
their viability. Another aspect is related to formation
of necrotic area inside of EBs, which is related to hy-
poxia and lack of access to nutrients and growth fac-
tors in this area.19,44
The Fluorescence Labeling of 2D and 3D Diﬀerentiated
Cells
After 2 weeks of diﬀerentiation, cells in monolayer
culture were stained for both pluripotent (NANOG,
OCT3/4, E-cadherin) and chondrogenic (type II col-
lagen, SOX9) markers (Fig. 2). Bioimaging evaluation
of the differentiated cells and comparison to the con-
trol hESC population, demonstrated a decreased
number of positive-labeled cells with pluripotent
markers, except for NANOG, which continued to be
expressed, although at a low level. This was likely
caused by the presence of FGF-2 in the medium, which
is crucial for maintaining pluripotency.
Evaluation of EBs at the ﬁrst time point (day 0) was
diﬃcult because of their ﬂattened structure and central
area rich in cells. This prevented positively labeled cells
being distinguished from the general cell population.
The condensed cells localized in the center of the ﬂat-
tened EBs were acknowledged as an artifact (Figs. 3a,
3c, and 3d—time point D0). As expected, pluripotent
marker expression decreased throughout the differen-
tiation process, whereby SOX2, NANOG signals were
less intense (Figs. 3a and 3b). Brachyury, the meso-
dermal marker (Fig. 3c), was observed from day 0
onwards, which conﬁrmed the presence of the meso-
dermal germ layer in the EBs. Prochondrogenic
markers SOX6 and SOX9 (Figs. 3d and 3e) were
clearly observed at day 21 in comparison to previous
time points, whereas the expression of CXCR4 (che-
mokine (C-X-C motif) receptor 4) (Fig. 4a) appeared
stable during differentiation. Immunoﬂuorescence
analysis of ECM components (type II collagen, chon-
droitin sulfate, heparan sulfate) (Figs. 4b–4d) at vari-
ous time points during EB transition to chondrocytes,
demonstrated increased expression of these markers.
Moreover, primary chondrocytes and differentiated
stem cells showed a similar extensive pattern of ECM
marker expression. Detection of type II collagen at day
21 conﬁrmed successful differentiation of the cells into
chondrocytes. b-catenin (Fig. 4e) signal was less in-
tense throughout the differentiation process.
FIGURE 2. Immunofluorescence staining of differentiated hESCs into chondrocytes in a monolayer. Fluorescence-labeled cells
for pluripotent (NANOG, OCT3/4, E-cadherin) and chondrocyte markers (SOX9, type II collagen) were used to evaluate the pro-
tocols for measurement of the mean gray intensity. Nuclei were stained using DAPI. Images were obtained using 3100 magnifi-
cation.
An Useful Tool to Monitor Differentiation of Human Embryonic Stem Cells 1849
The Evaluation of Mean Gray Signal Intensity
of IF-Labeled Cells
Analysis of monolayer (2D protocol) diﬀerenti-
ated stained cells demonstrated extremely signiﬁcant
changes (p< 0.001) when compared with the control
population (hECSs). Pluripotent marker (E-cad-
herin, OCT3/4, NANOG) (Figs. 5a–5c) expression
levels were decreased below those of the control cells
FIGURE 3. Immunofluorescence staining of various transcription factors during chondrogenic differentiation of EBs exposed to
TGF-b3. EBs at different time points were stained for pluripotent markers (NANOG, SOX2), mesodermal marker (Brachyury) and
prochondrogenic transcriptional factors (SOX6, SOX9). hESCs and ACCs were used as controls. Images were obtained using3100
magnification.
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(NANOG, OCT3/4, E-cadherin). Moreover, after
differentiation, chondrocyte markers such as colla-
gen type II and its expression regulator, SOX9 dis-
played elevated values of signal intensity (Figs. 5d
and 5e).
Between 0 and 21 days of EB (3D protocol) diﬀer-
entiation, major changes in ﬂuorescence intensity levels
were observed. Expression analysis of proteins
responsible for the state pluripotency (NANOG) dis-
played an extremely signiﬁcant diﬀerence (p< 0.001)
FIGURE 4. Immunofluorescence staining of ECM and surface proteins in EBs during chondrogenic differentiation. To confirm
hESC differentiation into chondrocytes, cells were stained for cartilage markers collagen type II and Wnt signaling pathway
activator, b-catenin. Cells were also labeled for chondroitin sulfate, heparan sulfate and CXCR4. To validate staining specificity,
hESCs and ACCs were used as controls. Cells were observed and images were obtained using 3100 magnification.
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FIGURE 5. Analysis of fluorescence intensity level of differentiated hESCs into chondrocytes in a monolayer. Differences
between the differentiated cell population (ChM + GFs) and controls (ACC; hESCs) were statistically significant (p< 0.001). Error
bars represent standard error of the mean (SEM).
SUCHORSKA et al.1852
when compared with the control cell population
(Fig. 6a). Differences in the level of signal intensity for
SOX2 between the differentiated cells and control
ACCs and hESCs were also extremely signiﬁcant
(p< 0.001). Differences between individual time points
were also extremely signiﬁcant (p< 0.001) (Fig. 6b).
Brachyury expression (Fig. 6c) tended to decrease,
with the level of signal being statistically signiﬁcant for
differentiated cells in comparison to control cells
(p< 0.05). Differences in Brachyury intensity signal
between day 0 and other time points were also highly
signiﬁcant (p< 0.01). Expression of SOX9 (Fig. 6d)
and SOX6 (Fig. 6e), represented by an increased level
of gray signal intensity, was caused by transformation
of cells into chondrocytes. There were no statistical
signiﬁcance differences of SOX9 intensity level at day
21 between differentiated cells and ACCs. Decreased
signal intensity of b-catenin was observed during dif-
ferentiation (Fig. 7a) with the difference between
control cells and time points being very signiﬁcant
(p< 0.001; p< 0.05). Supplementation of chondro-
genic medium with TGF-b3 did not signiﬁcantly
inﬂuence CXCR4 expression (Fig. 7b). After EB dif-
ferentiation, an increase in the level of ﬂuorescence
intensity of cartilage-speciﬁc ECM components (hep-
aran sulfate, type II collagen) was observed (Figs. 7c
and 7d, p< 0.001). Chondroitin sulfate (Fig. 7e) signal
intensity decreased between individual time points
under exposure to growth factors, which could be ex-
plained by cell migration (p< 0.01). However, the level
of ﬂuorescence intensity of labeled chondroitin sulfate
in ACCs and in the differentiated cells was almost
equal.
DISCUSSION
Immunoﬂuorescence labeling of cells is a fast and
inexpensive method of monitoring biological pro-
cesses. Converging the IF technique with contem-
porary bioinformatics approaches creates an oppor-
tunity to analyze and monitor not only the signal
intensity but also the time course of changes observed
within cells, whilst allowing statistical signiﬁcance to
be determined. The diﬀerentiation of hESCs into
chondrocytes in both monolayer (2D) and EB (3D)
resulted in heterogeneous populations of cells con-
taining chondrocyte-like population, as supported by
increased intensity of type II collagen and SOX9 sig-
nals after diﬀerentiation was complete. Expression of
these proteins is usually used as a criterion for chon-
drogenic cell diﬀerentiation. In monolayer culture
signal intensity of type II collagen was slightly higher
than in diﬀerentiated cells compared with ACCs. These
decreased values in ACCs could be correlated with loss
of function, phenotype and increased proliferation
during propagation of primary chondrocytes, what
was described in several studies.7,15 An increased mean
gray intensity was also observed for SOX9 in differ-
entiated cells, where differences between the control
and differentiated cells were notable. The increased
level of intensity of SOX9 signal in the differentiated
cells could also explain higher expression of type II
collagen, because SOX9 acts as a transcription factor
involved in regulation of COL2A1 expression. During
differentiation, the pluripotency of hESCs was signiﬁ-
cantly decreased. Changes were observed for OCT3/4
and NANOG, well-known markers of pluripotency.
These results were substantiated by very low expres-
sion of E-cadherin in comparison to the controls
(p< 0.001). This adhesive protein plays an important
role in maintaining the pluripotency state, as clearly
shown for induced murine pluripotent stem cells.45
Supplementation of prochondrogenic medium with
TGF-b3 resulted in increased production of ECM
components following 3D differentiation culture. Type
II collagen was present in EBs from day 0, which is not
surprising because EBs constitute a heterogeneous
group of cells, whilst at day 21 signal intensity was
signiﬁcantly increased. The presence of SOX6, but not
SOX9, was detected at day 0. Transcription factors
SOX6, SOX9, and L-SOX5 are crucial regulators of
expression of ACAN, which is responsible for the
synthesis of aggrecans and genes regulated by colla-
gens type II, IX, and XI.15,62
From the beginning of diﬀerentiation, chondroitin
sulfate was expressed in the diﬀerentiated cells and
control hESCs and ACCs. Expression of chondroitin
sulfate in hESCs has an important function during
early embryo development, alongside E-cadherin, to
maintain the balance between self-renewal and diﬀer-
entiation.21 Moreover, the pattern of signal and sur-
face coverage of this marker changed during
differentiation. After differentiation, the ECM area
was larger and less condensed than in the hESCs and
EBs at day 0, and resembled the ACC signal pattern.
Signal intensity decreased during differentiation and at
the end of the time course, differentiated cells gained a
similar level of intensity to ACCs. With respect to the
ECM component, heparan sulfate expression was
increased during differentiation. At day 21, the pattern
of ECM distribution in EBs, which had undergone
differentiation, was dissimilar to that of ACCs, but the
level of signal intensity of the labeled structures was
increased in comparison to day 0 and to ACCs. To
explain this occurrence, it should be noted that during
differentiation cell proliferation increased and after
day 14 cell dissociation was necessary. This caused
reduced cell attachment to the well surface. However,
the signal intensity was higher because of labeled
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intracellular compartments containing heparan, which
were more condensed than externalized and distributed
from ECM presented in ACC culture. Surprisingly,
this phenomena of internalization in other ECM
components were not observed. We suppose that, it
could be resulted by the lack of an appropriate cell
number sufﬁcient to co-stimulatory secretion of hep-
aran sulfate into outer membrane due to its important
role of cell–cell interactions by binding some receptors,
cytokines and integrins.49
From the beginning of the diﬀerentiation process,
the mesoderm marker Brachyury, which is encoded by
the T gene, was expressed. This was expected as EBs
spontaneously diﬀerentiate into cells of all three germ
layers. During embryonic development, the condensed
mesenchymal cells, stimulated by the TGF-b family of
proteins, create a cartilage nodule, which during fur-
ther diﬀerentiation, develops into limbs and joints.40
This is why many protocols for chondrocyte differen-
tiation use mesenchymal stem cell populations. The
lower ﬂuorescence intensity signal of Brachyury, even
after completion of the differentiation protocol, was
probably caused by transition of mesodermal cells into
chondrocytes.
During chondrogenic diﬀerentiation of EBs exposed
to TGF-b3, a lower signal intensity of b-catenin was
observed at day 21 in comparison to day 0. The main
cause of this decreased signal is connected with inter-
actions between SOX9 and b-catenin resulting in
decreased pluripotency.1 b-Catenin is present in mes-
enchymal cells but during mesenchymal cell conden-
sation and differentiation towards chondrocytes its
expression is down-regulated.14
After diﬀerentiation was completed, the signal
intensity of prochondrogenic markers was increased,
whilst expression of the pluripotent transcription fac-
tors, SOX2 and NANOG, was decreased, indicating
loss of pluripotency during diﬀerentiation of EB cells
into chondrocyte-like population. In accordance with
previously elaborated protocols, type II collagen pos-
itive cells were generated. Moreover, the expression of
transcription factors characteristic for chondrocytes
(SOX6, SOX9) was conﬁrmed. Similar expression
proﬁles during chondrocyte diﬀerentiation (down-reg-
ulation of pluripotency markers and upregulation of
prochondrogenic markers) were observed in various
protocols.18,26,36,39 To quantify the efﬁciency of
in vitro chondrogenesis, generally RT-qPCR expres-
sion analysis is used. Based on this analysis, the
expression of pluripotency markers such as NANOG,
OCT3/4, E-cadherin (CDH1), SOX2, and mesodermal
marker T (Brachyury) was decreased in various dif-
ferentiation protocols.26,39 CXCR4 gene expression
level during differentiation protocol performed by
Oldershaws’ group, were not statistically changed.
What more, the gene expression of prochondrogenic
markers were increased in the end of hESc differentiation
for ACAN (upregulated 2.5-fold), SOX6 (upregulated
3.6-fold), SOX9 (upregulated 5-fold) and COL2A1
(upregulated 370-fold).39 In our study to analyze the
differentiation efﬁcacy, we took advantage of immunoﬂu-
orescence as an optimal tool to analyze protein expres-
sion and location. Analysis of protein, as a ﬁnal product
of gene expression, allows to see the real functional
products of cells, because it is known, that not all of the
transcript can undergo translation.29
In our study, we presented the commonly used
method of indirect IF with slight analysis modiﬁca-
tions, which allows to semi-quantiﬁcation of the results
by taking under consideration the mean intensity of
signals in whole cell population on the image. Our
quantitative analysis correlates with recently published
data concerning chondrogenic diﬀerentiation of
pluripotent stem cells.9,26,39 The availability of free
bioinformatics tools such as ImageJ, enables to easily
analyze data and extract additional information from
pictures by modiﬁcation of program for own purpose.
The indirect immunoﬂuorescence is suitable technique
to detect various proteins of cytoskeleton, ECM, which
enables the visualization of the phenotype and struc-
ture of cells. However, in many published date
researcher mostly used indirect IF only to conﬁrm the
presence of protein without further analysis and
quantiﬁcation.22,28,32,39 A few studies over improve-
ments of articular cartilage functions or differentiation
of bone marrow cells towards chondrocytes have used
evaluation of IF images to count percentage of posi-
tively stained cells or measure the mean intensity by
manual drawing area of the signal.3,59 In presented
study by using threshold of RGB converted images
into 16-bit picture, we can describe the exact speciﬁc-
signal area and count mean gray value. Additionally,
the standardization of those results by ratio of posi-
tively stained cells in our case enabled to better
description of signal distribution in whole cell popu-
lation.
It is worth mentioning, that our method is suitable
only for cells, which are in monolayer cell culture,
because of the 3D structure such as EBs enable to
evaluate and interpret properly large mass of cells
(such as in day 0 in EBs diﬀerentiation protocol). For
3D objects it seems better to use confocal microscopy
or epi-ﬂuorescence microscopy. The results obtained in
this study conﬁrm the usefulness of IF analysis to
FIGURE 6. Analysis of mean gray signal intensity from cells
stained for transcription factors during chondrogenesis.
Changes between control cells (ACC, hES) and differentiated
EBs ((+)TGF-b3) were observed. Statistically significant scores
are highlighted (*=p< 0.05; **=p<0.01; ***=p< 0.001; ns—not
significant). Error bars represent SEM.
b
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FIGURE 7. Analysis of mean gray signal intensity of immunolabeled surface proteins and ECM markers during chondrogenic
differentiation of EBs. The mean gray intensity of EBs treated with TGF-b3 was compared with other cell populations signal
emissions. Statistical significance is highlighted: *=p< 0.05; **=p< 0.01; ***=p<0.001; ns—non-significant; nd—no data to com-
pare). Error bars represent SEM.
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monitor the level of signal intensities of distinct cell
populations during chondrogenesis and allows to track
the changes of hES during diﬀerentiation to chondro-
cyte-like cells.
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